89
Views
0
CrossRef citations to date
0
Altmetric
Review

Heat-shock Protein 60 and Cardiovascular Disease: A Paradoxical Role

&
Pages 151-161 | Published online: 28 Feb 2008

Bibliography

  • Ali A , BharadwajS, O‘CarrollR, Ovsenek N: HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopusoocytes. Mol. Cell. Biol., 18, 4949–4960 (1998).
  • Aligue R , Akhavan-NiakH, RussellP: A role for HSP 90 in cell cycle control: Wee1 tyrosine kinase activity requires interaction with HSP 90.EMBO, 13, 6099–6106 (1994).
  • Pratt WB : The HSP90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors.Proc. Soc. Exp. Biol. Med., 217, 420–434 (1998).
  • Hartson SD , MattsRL: Association of HSP 90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function.Biochemistry, 33, 8912–8920 (1994).
  • Kirby LB , MondyJS, BrophyCM: Balloon angioplasty induces heat shock protein 70 in human blood vessels.Ann. Vasc. Surg., 13, 475–479 (1999).
  • Knowlton AA , BrecherP, ApsteinCS: Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia.J. Clin. Invest., 87, 139–147 (1991).
  • Mehta HB , PopovichBK, DillmannWH: Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M.Circ. Res., 63, 512–517 (1988).
  • Nakano M , MannDL, KnowltonAA: Blocking the endogenous increase in HSP72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes.Circulation, 95, 1523–1531 (1997).
  • Kirchhoff SR , GuptaS, KnowltonAA: Cytosolic HSP60, apoptosis, and myocardial injury.Circulation, 105, 2899–2904 (2002).
  • Hutter JJ , MestrilR, TamEKW, Sievers RE, Dillmann WH, Wolfe CL: Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation, 94, 1408–1411 (1996).
  • Plumier JCL , RossBM, CurrieRWet al.: Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J. Clin. Invest., 95, 1854–1860 (1995).
  • Lau S , PatnaikN, SayenMR, MestrilR: Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury.Circulation, 96, 2287–2294 (1997).
  • Lin KM , LinB, LianIY, MestrilR, Scheffler I, Dillmann WH: Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation, 103, 1787–1792 (2001).
  • Bender AT , SilversteinAM, DemadyDRet al.: Neuronal nitric-oxide synthase is regulated by the HSP90-based chaperone system in vivo. J. Biol. Chem., 274, 1472–1478 (1999).
  • Shah V , WiestR, Garcia-CardenaG, CadelinaG, GroszmannRJ, SessaWC: HSP90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension.Am. J. Physiol., 277, g463–g468 (1999).
  • Russell KS , HaynesMP, Caulin-GlaserT, RosneckJ, SessaWC, BenderJ: Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release.J. Biol. Chem., 275, 5026–5030 (2000).
  • Soltys BJ , GuptaRS: Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (HSP60) in mammalian cells.Exp. Cell Res., 222, 16–27 (1996).
  • Lin L , KimSC, WangYet al.: HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am. J. Physiol., 293, H2238–H2247 (2007).
  • Ellis R : The Chaperonins. Academic Press, NY, USA (1996).
  • Shan YX , LiuTJ, SuHF, SamsamshariatA, MestrilR, WangPH: HSP10 and HSP60 modulate BCL-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells.J. Mol. Cell. Cardiol., 35, 1135–1143 (2003).
  • Veres A , SzamosiT, AblonczyMet al.: Complement activating antibodies against the human 60 kDa heat shock protein as an independent family risk factor of coronary heart disease. Eur. J. Clin. Invest., 32, 405–410 (2002).
  • Gupta S , KnowltonAA: Cytosolic HSP60, hypoxia and apoptosis.Circulation, 106, 2727–2733 (2002).
  • Gupta S , KnowltonAA: HSP60, BAX, apoptosis and the heart.J. Cell. Mol. Med., 9, 51–58 (2005).
  • Gupta S , KnowltonAA: HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway.Am. J. Physiol. Heart Circ. Physiol., 292, H3052–H3056 (2007).
  • Knowlton AA , KapadiaS, Torre-AmioneGet al.: Differential expression of heat shock proteins in normal and failing human hearts. J. Mol. Cell. Cardiol., 30, 811–818 (1998).
  • Latif N , TaylorPM, KhanMA, Yacoub MH, Dunn MJ: The expression of heat shock protein 60 in patients with dilated cardiomyopathy. Basic Res. Cardiol., 94, 112–119 (1999).
  • Tanonaka K , FuruhamaKI, YoshidaHet al.: Protective effect of heat shock protein 72 on contractile function in the perfused failing heart. Am. J. Physiol., 281, H215–H222 (2001).
  • Fiszer Kierzkowska A , WysockaA, Jarzab M, Lisowska K, Krawczyk Z: Structure of gene flanking regions and functional analysis of sequences upstream of the rat HSP70.1 stress gene. Biochim. Biophys. Acta, 1625, 77–87 (2003).
  • Chen H , ShanYX, YangTL, LinH, ChenJ, LinSJ: Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium.Diabetes, 54, 175–181 (2005).
  • Lai HC , LiuTJ, TingCTet al.: Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60. Am. J. Physiol. Endocrinol. Metab., 292, E292–E297 (2007).
  • Schäfler A , KirmanoglouK, PecherP, HannekumA, SchumacherB: Overexpression of heat shock protein 60/10 in myocardium of patients with chronic atrial fibrillation.Ann. Thorac. Surg., 74, 767–770 (2002).
  • Yang M , TanH, ChengLet al.: Expression of heat shock proteins in myocardium of patients with atrial fibrillation. Cell Stress Chaperones, 12, 142–150 (2007).
  • Mandal K , JahangiriM, MukhinM, PolonieckiJ, CammAJ, XuQ: Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation.Circulation, 110, 2588–2590 (2004).
  • Oc M , UcarH, PinarAet al.: Heat shock protein 60 antibody. A new marker for subsequent atrial fibrillation development. Saudi Med. J., 28, 844–847 (2007).
  • Hochleitner BW , HochleitnerEOet al., Obrist P : Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol., 20, 617–623 (2000).
  • Issac TT , DokainishH, LakkisNM: Role of inflammation in initiation and perpetuation of atrial fibrillation.J. Am. Coll. Cardiol., 50, 2021–2028 (2007).
  • Ohashi K , BurkartV, FloheS, KolbH: Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex.J. Immunol., 164, 558–561 (2000).
  • Carroll M : Innate immunity in the etiopathology of autoimmunity.Nat. Immunol., 2, 1089–1090 (2001).
  • de Graaf R , KloppenburgG, Kitslaar PJHM, Bruggeman CA, Stassen F: Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect., 8, 1859–1865 (2006).
  • Hollestelle SCG et al. , de Vries MR, van Keulen JK : Toll-like receptor 4 is involved in outward arterial remodeling. Circulation, 109, 393–839 (2004).
  • Schoneveld AH , HoeferI, SluijterJPG, LamanJ, de Kleijn D, Pasterkamp G: Atherosclerotic lesion development and Toll-like receptor 2 and 4 responsiveness. Atherosclerosis (2008) (In Press).
  • de Graeff Meeder E , RijkersG, Voorhorst-OginkMet al.: Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr. Res., 34, 424–428 (1993).
  • de Graeff Meeder E et al. , Van der Zee R, Rijkers G : Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet, 8754, 1368–1372 (1991).
  • Pope R , LovisR, GuptaRS: Activation of synovial fluid T lymphocytes by 60-kd heat-shock proteins in patients with inflammatory synovitis.Arthritis Rheum., 35, 43–48 (1992).
  • Res P , SchaarC, BreedveldFet al.: Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet, 2, 478–480 (1988).
  • Boog C et al. , de Graeff-Meeder E, Lucassen M : Two monoclonal antibodies generated against human HSP60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J. Exp. Med., 175, 1805–1810 (1992).
  • Jamin C , DugúeC, AlardJEet al.: Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to HSP60 in vasculitis-associated systemic autoimmune disease. Arthritis Rheum., 52, 4028–4038 (2005).
  • Dieude M , SencecalJL, RaymondY: Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.Arthritis Rheum., 50, 3221–3231 (2004).
  • Alard JE , DueymesM, YouinouP, JaminC: Modulation of endothelial cell damages by anti-HSP60 autoantibodies in systemic autoimmune diseases.Autoimmun. Rev., 6, 438–443 (2007).
  • Wick G , KnoflachM, XuQ: Autoimmune and inflammatory mechanisms in atherosclerosis.Annu. Rev. Immunol., 22, 361–403 (2004).
  • Kiechl S , EggerG, MayrMet al.: Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation, 103, 1064–1070 (2001).
  • Schattner A , Rager-ZismanB: Virus induced autoimmunity.Rev. Infect. Dis., 12, 204–222 (1990).
  • Chen W , SyldathU, BellmannK, BurkartV, KolbH: Human 60-kDa heat-shock protein: a danger signal to the innate immune system.J. Immunol., 162, 3212–3219 (1999).
  • Wallin R , LundqvistA, MoréS, von Bonin A, Kiessling R, Ljunggren H: Heat-shock proteins as activators of the innate immune system. Trends Immunol., 23, 130–135 (2002).
  • Tsan MF , GaoB: Cytokine function of heat shock proteins.Am. J. Physiol. Cell Physiol., 286, C739–C744 (2004).
  • Xu Q , DietrichH, SteinerHJet al.: Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol., 12, 789–799 (1992).
  • Foteinos G , AfzalAR, MandalK, Jahangiri M, Xu Q: Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation, 112, 1206–1213 (2005).
  • George J , AfekA, GilburdB, ShoenfeldY, HaratsD: Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice.J. Am. Coll. Cardiol., 38, 900–905 (2001).
  • Shoenfeld Y , HaratsD, GeorgeJ: Heat shock protein 60/65, b2-glycoprotein I and oxidized LDL as players in murine atherosclerosis.J. Autoimmun., 15, 199–202 (2000).
  • Xu Q , WillemsJL, MarosiMet al.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet, 341, 255–259 (1993).
  • Xu Q , KiechlS, MayrMet al.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation, 100, 1169–1174 (1999).
  • Knoflach M , KiechlS, KindMet al.: Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation, 108, 1064–1069 (2003).
  • Knoflach M , KiechlS, MayrlBet al.: T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis, 195, 333–338 (2007).
  • Soltys BJ , GuptaRS: Cell surface localization of the 60 kDa heat shock chaperonin protein (HSP60) in mammalian cells.Cell Biol. Int. Rep., 21, 315–320 (1997).
  • Pockley AG , BulmerJ, HanksB, WrightB: Identification of human heat shock protein 60 (HSP60) and anti-HSP60 antibodies in the peripheral circulation of normal individuals.Cell Stress Chaperones, 4, 29–35 (1999).
  • Shamaei Tousi A , D‘AiutoF, NibaliLet al.: Differential regulation of circulating levels of molecular chaperones in patients undergoing treatment for periodontal disease. PLoS One, 2, e1198 (2007).
  • Shamaei Tousi A , SteptoeA, O‘DonnellKet al.: Plasma heat shock protein 60 and cardiovascular disease risk: the role of psychosocial, genetic and biological factors. Cell Stress Chaperones, 12, 384–392 (2007).
  • Singh B , PatelHV, RidleyRG, FreemanKB, GuptaRS: Mitochondrial import of the human chaperonin (HSP60) protein.Biochem. Biophys. Res. Commun., 169, 391–396 (1990).
  • Pockley AG , WuR, LemneC, KiesslingR, de Faire U, Frostegard J: Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension, 36, 303–307 (2000).
  • Pockley AG , de Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J: Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J. Hypertens., 20, 1815–1820 (2002).
  • Xu Q , SchettG, PerschinkaHet al.: Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation, 102, 14–20 (2000).
  • Xiao Q , MandalK, SchettGet al.: Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical Significance determined in a follow-up study. Stroke, 36, 2571–2576 (2005).
  • Wright B , CortonJ, El-NahasA, WoodR, PockleyA: Elevated levels of circulating heat shock protein 70 (HSP70) in peripheral and renal vascular disease.Heart Vessels, 15, 18–22 (2000).
  • Shamaei-Tousi A , StephensJW, BinRet al.: Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur. Heart J., 27, 1565–1570 (2006).
  • Anand SS , YusufS, VuksanVet al.: Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic Groups (SHARE). Lancet, 353, 279–284 (2000).
  • Giannessi D , CaselliC, VitaleRLet al.: A possible cardioprotective effect of heat shock proteins during cardiac surgery in pediatric patients. Pharmacol. Res., 48, 519–529 (2003).
  • Anderson JL , MuhlesteinJB: Antibiotic trials for coronary artery disease.Tex. Heart Inst. J., 31, 33–38 (2004).
  • Anderson JL , MuhlesteinJB, CarlquistJet al.: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation, 99, 1540–1547 (1999).
  • Schett G , MetzlerB, KleindienstRet al.: Myocardial injury leads to a release of heat shock protein (HSP) 60 and a suppression of the anti-HSP65 immune response. Cardiovasc. Res., 42, 685–695 (1999).
  • Maron R , SukhovaG, FariaAMet al.: Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation, 106, 1708–1715 (2002).
  • van Puijvelde GHM et al. , van Es T, van Wanrooij EJA : Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 27, 2677–2683 (2007).
  • Harats D , YacovN, GilburdB, ShoenfeldY, GeorgeJ: Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions.J. Am. Coll. Cardiol., 40, 1333–1338 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.